Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Briacell Therapeutics stock
Learn how to easily invest in Briacell Therapeutics stock.
Briacell Therapeutics Corp is a biotechnology business based in the US. Briacell Therapeutics shares (BCTX) are listed on the NASDAQ and all prices are listed in US Dollars. Briacell Therapeutics employs 5 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Briacell Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BCTX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Briacell Therapeutics stock price (NASDAQ: BCTX)Use our graph to track the performance of BCTX stocks over time.
Briacell Therapeutics shares at a glance
|Latest market close||$5.37|
|52-week range||$4.06 - $12.47|
|50-day moving average||$6.92|
|200-day moving average||$7.21|
|Wall St. target price||$20.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.95|
Buy Briacell Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Briacell Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Briacell Therapeutics price performance over time
|1 week (2022-09-23)||-8.36%|
|1 month (2022-09-01)||-33.62%|
|3 months (2022-07-01)||-11.68%|
|6 months (2022-04-01)||-48.12%|
|1 year (2021-10-01)||-34.03%|
|2 years (2020-09-27)||N/A|
|3 years (2019-10-01)||10,640.00%|
|5 years (2017-09-27)||4,673.33%|
Briacell Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-23.47%|
|Return on equity TTM||-46.36%|
|Market capitalisation||$91.1 million|
TTM: trailing 12 months
Briacell Therapeutics share dividends
We're not expecting Briacell Therapeutics to pay a dividend over the next 12 months.
You may also wish to consider:
- Amgen (AMGN.US) (3.42% forward annual dividend yield)
Have Briacell Therapeutics's shares ever split?
Briacell Therapeutics's shares were split on a 1:300 basis on 2 January 2020. So if you had owned 300 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Briacell Therapeutics shares – just the quantity. However, indirectly, the new 29900% higher share price could have impacted the market appetite for Briacell Therapeutics shares which in turn could have impacted Briacell Therapeutics's share price.
Briacell Therapeutics share price volatility
Over the last 12 months, Briacell Therapeutics's shares have ranged in value from as little as $4.06 up to $12.47. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Briacell Therapeutics's is 1.3241. This would suggest that Briacell Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put Briacell Therapeutics's beta into context you can compare it against those of similar companies.
- Amgen (AMGN.US): 0.5637
- BeiGene (BGNE.US): 0.6468
- Corcept Therapeutics Incorporated (CORT.US): 0.5585
Briacell Therapeutics overview
BriaCell Therapeutics Corp. , a clinical stage immuno-oncology-focused biotechnology company, engages in developing immunotherapies for the management of cancer. Its lead drug candidate is Bria-IMT, a whole-cell cancer vaccine that is in Phase I/IIa clinical trials in combination with the immunotherapy development candidates retifanlimab. The company is also developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer. It has a non-exclusive clinical trial collaboration with Incyte Corporation to evaluate the effects of combinations of novel clinical candidates; and a cooperative research and development agreement with the National Cancer Institute to investigate the mechanism of action of novel off-the-shelf personalized therapeutics for cancer. The company is headquartered in West Vancouver, Canada. .
Briacell Therapeutics in the news
BriaCell to Present New Clinical Data at the 2022 San Antonio Breast Cancer Symposium® December 6th and 7th
BriaCell Partners with Caris Life Sciences® to Expand Patient Outreach and Molecular Profiling
BriaCell Announces Presentation at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Frequently asked questionsWhat percentage of Briacell Therapeutics is owned by insiders or institutions?
Currently 25.004% of Briacell Therapeutics shares are held by insiders and 20.768% by institutions. How many people work for Briacell Therapeutics?
Latest data suggests 5 work at Briacell Therapeutics. When does the fiscal year end for Briacell Therapeutics?
Briacell Therapeutics's fiscal year ends in July. Where is Briacell Therapeutics based?
Briacell Therapeutics's address is: Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1 What is Briacell Therapeutics's ISIN number?
Briacell Therapeutics's international securities identification number is: CA10778Y3023
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert